Sensitization of tumor cells to chemotherapy by natural products: A systematic review of preclinical data and molecular mechanisms

被引:70
|
作者
de Oliveira, Raimundo Goncalves Junior [1 ]
Christiane Adrielly, Alves Ferraz [2 ]
Guedes da Silva Almeida, Jackson Roberto [2 ]
Grougnet, Raphael [3 ]
Thiery, Valerie [1 ]
Picot, Laurent [1 ]
机构
[1] Univ La Rochelle, CNRS, UMRi 7266, LIENSs, F-17042 La Rochelle, France
[2] Fed Univ San Francisco Valley, Ctr Studies & Res Med Plants, BR-56306000 Petrolina, Brazil
[3] Paris Descartes Univ, Lab Pharmacognosy, CNRS, UMR 8638, F-75006 Paris, France
关键词
Cancer; Chemotherapy; Chemosensitization; Drug resistance; Natural products; NF-KAPPA-B; HUMAN COLORECTAL-CANCER; STAT3 SIGNALING PATHWAY; REGULATED GENE-PRODUCTS; TRAIL-INDUCED APOPTOSIS; HUMAN BREAST-CANCER; DEATH RECEPTOR 5; IN-VITRO; DOWN-REGULATION; MULTIDRUG-RESISTANCE;
D O I
10.1016/j.fitote.2018.02.025
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Purpose: Tumor cells are spontaneously or adaptively resistant to chemotherapeutic drugs, eventually leading to the selection of multiresistant cells responsible for tumor growth and metastasis. Chemosensitization of tumor cells to conventional drugs using non-toxic natural products is a recent and innovative strategy aiming to increase the cytotoxic efficiency of anticancer drugs, limit their toxic side effects and delay the appearance of acquired chemoresistance. This systematic review summarizes data obtained from preclinical studies reporting the use of natural products to sensitize tumor cells to chemotherapeutic agents. It also details the cellular and molecular mechanisms involved in chemosensitization. Design: Search terms were combined and used to retrieve English language reports in PubMed, Science Direct and Scopus databases, published until October 2017. All articles were carefully analyzed and data extraction was conducted through standardized forms. Methodological quality assessment of in vivo studies was also performed. Results: From a total of 669 articles surveyed, 104 met the inclusion criteria established. The main studied compounds as chemosensitizers were phenolic derivatives (26.9%) and flavonoids (17.3%). Most reports were authored by researchers from China (33.7%) and USA (26.9%). A large number of articles were published from 2011 to 2015 (50.0%), suggesting that the use of natural products as chemosensitizers is a recent issue. In vivo studies were conducted mainly using xenograft models, which were considered of moderate methodological quality. Conclusion: Several natural products, belonging to diverse chemical families, are potent chemosentisizers in tumor cells enhancing the cytotoxicity of conventional drugs. These molecules usually have a pleiotropic effect on different molecular targets, acting on several cellular and molecular processes with low selectivity. All studied molecules were obtained from terrestrial plants and major developments should arise from future studies, considering the chemodiversity of molecules purified from other terrestrial taxa and marine organisms.
引用
收藏
页码:383 / 400
页数:18
相关论文
共 50 条
  • [31] Natural products to prevent drug resistance in cancer chemotherapy: a review
    Yuan, Renyikun
    Hou, Ying
    Sun, Wen
    Yu, Jie
    Liu, Xin
    Niu, Yanan
    Lu, Jin-Jian
    Chen, Xiuping
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2017, 1401 (01) : 19 - 27
  • [32] Targeting CD8+T cells with natural products for tumor therapy: Revealing insights into the mechanisms
    Wang, Yuke
    Zeng, Yan
    Yang, Wenyong
    Wang, Xiuxuan
    Jiang, Jingwen
    PHYTOMEDICINE, 2024, 129
  • [33] Natural products modulating interleukins and other inflammatory mediators in tumor-bearing animals: A systematic review
    Gandhi, Gopalsamy Rajiv
    Antony, Poovathumkal James
    Lana, Maria Julia Miranda de Paula
    da Silva, Brenda Fernandes Xavier
    Oliveira, Roberta Vieira
    Jothi, Gnanasekaran
    Hariharan, Govindasamy
    Mohana, Thiruchenduran
    Gan, Ren-You
    Gurgel, Ricardo Queiroz
    Cipolotti, Rosana
    Quintana Junior, Lucindo Jose
    PHYTOMEDICINE, 2022, 100
  • [34] Blockade of behavioral sensitization by MK-801: fact or artifact? A review of preclinical data
    T. M. Tzschentke
    W. J. Schmidt
    Psychopharmacology, 2000, 151 : 142 - 151
  • [35] Antinociceptive effect of plant-based natural products in chemotherapy-induced peripheral neuropathies: A systematic review
    Santos, Wagner Barbosa Da Rocha
    Guimaraes, Juliana Oliveira
    Pina, Licia Tairiny Santos
    Serafini, Mairim Russo
    Guimaraes, Adriana Gibara
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [36] Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review
    Gunjur, Ashray
    Balasubramanian, Adithya
    Hafeez, Umbreen
    Menon, Siddharth
    Cher, Lawrence
    Parakh, Sagun
    Gan, Hui Kong
    JOURNAL OF NEURO-ONCOLOGY, 2022, 159 (03) : 539 - 549
  • [37] Potential of Natural Products in the Treatment of Glioma: Focus on Molecular Mechanisms
    Sheida, Amirhossein
    Farshadi, Marjan
    Mirzaei, Amirhossein
    Khalilabad, Shakiba Najjar
    Zarepour, Fatemeh
    Taghavi, Seyed Pouya
    Khabr, Maryam Sadat Hosseini
    Ravaei, Fatemeh
    Rafiei, Sara
    Mosadeghi, Kimia
    Yazdani, Mohammad Sepehr
    Fakhraie, Ali
    Ghattan, Alireza
    Fard, Mohammad Masoud Zamani
    Shahyan, Maryam
    Rafiei, Moein
    Rahimian, Neda
    Zavareh, Sayyed Alireza Talaei
    Mirzaei, Hamed
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2024, : 3157 - 3208
  • [38] Molecular mechanisms of ferroptosis and its antitumor applications in natural products
    Yu, Dianping
    Wang, Qun
    Zhang, Qing
    Cai, Minchen
    Liu, Sanhong
    Zhang, Weidong
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2023, 55 (09) : 1337 - 1347
  • [39] Blockade of behavioral sensitization by MK-801: fact or artifact? A review of preclinical data
    Tzschentke, TM
    Schmidt, WJ
    PSYCHOPHARMACOLOGY, 2000, 151 (2-3) : 142 - 151
  • [40] Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review
    Ashray Gunjur
    Adithya Balasubramanian
    Umbreen Hafeez
    Siddharth Menon
    Lawrence Cher
    Sagun Parakh
    Hui Kong Gan
    Journal of Neuro-Oncology, 2022, 159 : 539 - 549